Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $287.7K | $181.4K | $163.3K | $461.1K | $364.8K | $4.3M | $29.5M | $28.8M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $2.2M | $20.8M | $19.4M |
| Gross profit | $287.7K | $181.4K | $163.3K | $461.1K | $364.8K | $2.1M | $8.7M | $9.4M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 48.5% | 29.4% | 32.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$1.2M | −$2.5M | −$36.6M | −$3.3M | −$2.3M | −$21.2M | −$37.9M | −$25.8M |
| EBITDA | −$1.2M | −$2.5M | −$36.6M | −$3.2M | −$2.0M | −$21.0M | −$29.8M | −$11.0M |
| Net income | −$1.4M | −$1.5M | −$38.4M | −$4.4M | −$1.7M | −$21.2M | −$33.9M | −$10.7M |
| Net margin | -474.6% | -850.7% | -23494.2% | -944.3% | -475.9% | -491.3% | -115.2% | -37.2% |
| EPS (diluted) | -0.51 | -0.54 | -1.86 | -0.13 | -0.03 | -0.18 | -0.23 | -0.01 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ACGI.
No tracked institution reports a position in ACGI as of their last filing.
No one on the platform has traded ACGI yet.
| $10127 |
| — |
| HTDSHard to Treat Diseases Inc. | $0.00 | +0.00% | $109647 | — |
| IMEXFImagin Medical Inc. | $0.00 | +0.00% | $1083 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.